CEACAM6 and acute lymphoblastic leukemia: CD9, CD123, CD66c, CD81, CD24, TdT, CD58, and surface membrane immunoglobulin light chain kappa/lambda (SmIgK/L) were evaluated for their discriminatory power between BCPs and BCP-ALL cells based on the Automatic Population Separator (APS), included in the Infinicyt software (Cytognos SL; version 2.0.6.b.001).